BB's Stock Haven

[albert]

Yes that is correct. This is not a profile, but a stock pick under a penny that had a 52 week high over $1.HCCF just launched a new site http://biz.yahoo.com/prnews/050422/cgf040.html?.v=4 HEE Corporation) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the web site marks the first time HPB-84 has been available for sale to the public.

The HEE Corporation

The HEE Corporation (OTCPK:HCCF) is a publicly traded company that was founded for the purpose of providing a corporate vehicle for marketing a new and extremely promising nutriceutical for Type II Diabetes. This nutriceutical was developed and tested in India . HEE Corp has the world-wide rights (exclusive of India ) and is currently bringing it to the market in the United States and Internationally. Based upon the highly successful results of the product in India , and the testimonials from those who have taken it here in the USA, HEE Corp is very excited about what we can do with the product world-wide.

Type II Diabetes has reached epidemic levels in The United States with 18.2 million confirmed cases and an estimated 5 million (nearly one-third of that total) not yet aware that they have Diabetes! Diabetes is the fifth leading cause of death by disease in the U.S.

Diabetes is now a modern-day epidemic, with some 171,000,000 people around the globe are estimated to have diabetes and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Type II Diabetes is the cause of many other ailments including heart disease, renal failure, blindness, skin problems and even loss of limbs. While there are treatments available for Diabetes they are often focused on treating the symptoms and not on eradicating the actual disease. Many of the side effects of prescription drugs for diabetes are uncomfortable for the patient and even dangerous.

While this is a relatively new product here in the USA , the promise of this revolutionary product cannot be ignored. While nutriceutical treatments have not received a huge following in the United States they have large followings in the rest of the world. HEE might not change medical history, but our product certainly does have a positive effect on those people who suffer from Type II Diabetes.

Please be aware that this stock trades in 20-30% ranges during the day. We have been adding to our position under .01.The nutriceutical arena will be hot this year.We own a large position bought in the open market and can sell at any time.

1 Year price target : .30 Cents

This Is a PR that HCCF came out with today. http://biz.yahoo.com/prnews/050503/cgtu041.html?.v=9

Read The last paragraph:



Wil graag informatie over HTB84 pil tegen diabetes